Tuberville Joins CLEAR LABELS Act to Protect American Patients Through Drug Origin Transparency

February 9, 2026 - WASHINGTON, D.C. – U.S. Senator Tommy Tuberville (R-Alabama) joined U.S. Sen. Rick Scott (R-Florida) in introducing the Consumers Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act to add country of origin labeling requirements to the United States' prescription drug supply chain. Sen. Tuberville recently highlighted Alabama's Oxford Pharmaceuticals' efforts to increase American generic drug production.

Many prescription drugs, and their active pharmaceutical ingredients (APIs), are manufactured overseas, particularly in China and India. Yet, current federal labeling requirements to do not require public disclosure of where those ingredients or finished products are made. As a result, patients, pharmacists, and health care providers lack the upfront visibility into the origins of their medications. The CLEAR LABELS Act would require prescription drug labels to disclose the original manufacturers or prescription drugs and APIs to ensure patients, providers, and regulators have clear, upfront information about where the drugs they rely on day-after-day are made.

"Most Americans are so used to taking medicines that they don't stop to think where it comes from," said Sen. Tuberville. "We have become way too reliant on foreign supply chains for our generic medicines-and it's putting our health at risk. Americans deserve to know where their medicines are being made and what ingredients they contain. It's common sense. I'm proud to join Sen. Rick Scott in introducing the CLEAR LABELS Act to give Americans the truth so they can make more informed decisions when it comes to the medicines they consume."

"As parents and grandparents, we do everything we can to make informed, safe decisions that keep our families safe and healthy," said Sen. Scott. "But right now, families are being kept in the dark about where their drugs are coming from. America's drug supply is dependent on our enemies like China and countries such as India to manufacture our drugs and ingredients, often with limited transparency and oversight. This broken process leaves patients in the dark about where their drugs come. Families deserve to have confidence that the medicines they take are safe, regulated, and clearly labeled. That's why I'm leading the bipartisan CLEAR LABELS Act with Ranking Member Gillibrand to add country of origin labels to your medicines and help ensure every American can feel comfortable knowing what's in their medicine cabinet."